PYC Therapeutics Ltd
ASX:PYC

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
ASX:PYC
Watchlist
Price: 1.45 AUD 2.84% Market Closed
Market Cap: 676.6m AUD
Have any thoughts about
PYC Therapeutics Ltd?
Write Note

Wall Street
Price Targets

PYC Price Targets Summary
PYC Therapeutics Ltd

Wall Street analysts forecast PYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PYC is 3.52 AUD with a low forecast of 2.42 AUD and a high forecast of 5.04 AUD.

Lowest
Price Target
2.42 AUD
67% Upside
Average
Price Target
3.52 AUD
143% Upside
Highest
Price Target
5.04 AUD
248% Upside
PYC Therapeutics Ltd Competitors:
Price Targets
CDNA
CareDx Inc
67% Upside
SNDX
Syndax Pharmaceuticals Inc
185% Upside
PAR
Paradigm Biopharmaceuticals Ltd
23% Upside
MRNA
Moderna Inc
98% Upside
7774
Japan Tissue Engineering Co Ltd
172% Upside
KTRA
Kintara Therapeutics Inc
143% Upside
IOVA
Iovance Biotherapeutics Inc
229% Upside
MDGL
Madrigal Pharmaceuticals Inc
23% Upside

Revenue
Forecast

Revenue Estimate
PYC Therapeutics Ltd

The compound annual growth rate of PYC Therapeutics Ltd's revenue for the next 3 years is 18%.

N/A
Past Growth
18%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
PYC Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
PYC Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PYC's stock price target?
Price Target
3.52 AUD

According to Wall Street analysts, the average 1-year price target for PYC is 3.52 AUD with a low forecast of 2.42 AUD and a high forecast of 5.04 AUD.

What is PYC Therapeutics Ltd's Revenue forecast?
Projected CAGR
18%

The compound annual growth rate of PYC Therapeutics Ltd's revenue for the next 3 years is 18%.

Back to Top